智通财经APP讯,兆科眼科-B(06622)发布公告,中国国家药品监督管理局最近受理环孢素眼用凝胶(公司核心产品之一,前称环孢素A眼凝胶)的新药上市申请。
透过与国家药监局就环孢素眼用凝胶进行全面沟通及新药申请前讨论,公司已接获国家药监局的书面回复,同意公司基于先前完成的第III期临床试验(COSMO研究)结果以及对该项临床试验进行的进一步数据挖掘及事后分析提交的新药申请。
智通财经APP讯,兆科眼科-B(06622)发布公告,中国国家药品监督管理局最近受理环孢素眼用凝胶(公司核心产品之一,前称环孢素A眼凝胶)的新药上市申请。
透过与国家药监局就环孢素眼用凝胶进行全面沟通及新药申请前讨论,公司已接获国家药监局的书面回复,同意公司基于先前完成的第III期临床试验(COSMO研究)结果以及对该项临床试验进行的进一步数据挖掘及事后分析提交的新药申请。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.